Skip to content

When the Numbers Lie: Why Your NICU Baby’s Blood Pressure Might Be Lying to You

SHARE VIA:

It’s 3 a.m. on the neonatal unit, and you’re standing beside the incubator of Baby J, a 26-weeker now at day two of life. His mean arterial pressure sits reassuringly at 28 mmHg, right at that magic “gestation in weeks” number everyone talks about. The nurse documented it. The consultant’s happy. But something feels off.

Baby J’s peripheries are mottled and cool. His capillary refill is sluggish at four seconds. The lactate from an hour ago came back at 4.2 mmol/L, and he’s needing increasing ventilator support despite surfactant. His urine output has dribbled to 0.5 mL/kg/hr. You stare at that blood pressure reading again. It’s normal. So why does he look so rubbish?

Welcome to one of neonatal intensive care’s most deceptive traps: the tyranny of the blood pressure number. We’ve been taught to worship the altar of mean arterial pressure, but what if that single number is giving us false reassurance while tissue perfusion quietly collapses? What if Baby J’s “normal” BP is masking a cardiovascular story we’re completely missing?

Let’s talk about the monitoring tools that can help us see what’s really happening beyond that blood pressure cuff.

Why Blood Pressure Isn’t Enough?

Blood pressure tells us about driving pressure in the arterial system, but it reveals almost nothing about what’s happening at the tissue level. Think of it like checking the water pressure in your pipes while ignoring whether water is actually reaching the taps.

In the NICU, this matters enormously. A preterm baby can maintain adequate blood pressure through compensatory vasoconstriction even as cerebral, renal, and splanchnic perfusion tanks. That 26-weeker with a textbook MAP of 28 mmHg might be achieving it by clamping down peripheral vessels so hard that blood flow to vital organs has dropped dangerously low. Conversely, a baby with a PDA might have a low diastolic pressure but excellent systemic blood flow.

Baby J’s situation reflects this disconnect. His BP is acceptable, but his clinical picture (cool peripheries, rising lactate, oliguria) suggests his tissues aren’t getting what they need. His body is doing everything it can to defend that blood pressure number we’re fixated on, but he’s paying for it with organ perfusion. We need to look deeper.

NIRS: Windows into Tissue Oxygenation

Near-infrared spectroscopy gives us something beautifully simple: real-time measurement of regional tissue oxygen saturation. NIRS uses light wavelengths that penetrate tissue to measure the ratio of oxygenated to deoxygenated haemoglobin in the microcirculation beneath the sensor. It’s non-invasive, continuous, and can be placed over different organs.

In practice, we most commonly monitor cerebral NIRS (placing sensors on the forehead) and sometimes splanchnic NIRS (over the abdomen) or renal NIRS (over the flanks). What you are looking for is not the absolute number but the trend and the relationship to systemic saturations. The cerebral-to-systemic oxygen saturation ratio (the fractional tissue oxygen extraction, or FTOE) indicates whether the brain is working harder to extract oxygen (a sign that oxygen delivery might be difficult).

Pros:

  • Continuous, real-time regional perfusion data
  • Non-invasive and well-tolerated
  • Can detect problems before systemic signs appear
  • Helps guide transfusion and haemodynamic intervention

Cons:

  • Affected by sensor placement and ambient light
  • No universally agreed “normal” ranges
  • Can’t tell you why the saturations are low
  • Requires interpretation alongside other clinical data

Back to Baby J: You place cerebral NIRS sensors on his forehead. His cerebral saturation reads 40% while his pre-ductal SpO₂ is 92%. That is FTOE of 0.57 calculated through the following Formula :(SpO2-rSO2)/SpO2.

Normoxia FTOE is defined as FTOE >0.1 and ≤0.4, hypoxia FTOE as FTOE > 0.4, and Hyperoxia FTOE as FTOE ≤ 0.1. From the above, this means that baby J has high FTOE (his brain is extracting more oxygen than it should, suggesting oxygen delivery is compromised). Despite that “normal” blood pressure, his brain isn’t getting adequately perfused. Now you have objective data that aligns with your clinical instincts.

Electrical Cardiometry: The Flow Behind the Pressure

Electrical cardiometry measures cardiac output non-invasively by analysing changes in thoracic electrical conductivity during the cardiac cycle. As blood is ejected from the heart, the orientation of red blood cells changes from random to aligned, altering electrical conductivity across the chest. By measuring these changes, EC calculates stroke volume and, combined with heart rate, gives you cardiac output.

In neonates, this technology has been validated and gives you beat-to-beat cardiac output trends. You’re seeing litres per minute per kilogram and variations in stroke volume. Suddenly, you’re not just measuring pressure, you’re measuring flow.

The real power comes from trending. Is cardiac output dropping despite stable blood pressure? That tells you systemic vascular resistance is rising to compensate. Is cardiac output high but pressure low? You might be looking at a significant PDA or septic vasodilation.

Pros:

  • Completely non-invasive with just four ECG-style electrodes
  • Provides continuous cardiac output monitoring
  • Helps differentiate between cardiac and vascular causes of instability
  • Can guide fluid versus inotrope decisions

Cons:

  • Accuracy can be affected by movement and poor electrode contact
  • Less reliable with significant arrhythmias
  • Requires training to interpret trends properly
  • Not a direct measure (relies on algorithms)

You attach EC monitoring to Baby J. His cardiac output drops from 240 to 150 mL/min (lower than expected for a day-two preterm baby).

In this case, his cardiac output dropped, and his systemic vascular resistance is markedly elevated. Now the picture becomes clearer: he’s maintaining blood pressure by constricting his vessels, but his cardiac output is inadequate. His heart isn’t generating enough flow, and his body is compensating by squeezing down the pipes. That’s why his perfusion is poor despite acceptable pressures.

Below is a table for normal ranges of cardiac output for different gestational age groups.

Gestational ageCardiac output
≤28230ml/min ± 30
29-30290 ml/min ± 60
31-32350 ml/min + 70
33-34350 ml/min ± 70
35-36430 ml/min ± 80
37-38470 ml/min ± 100
39-41530 ml/min ± 140

N.B. Although it would be preferred to measure cardiac output accurately, it might be more useful to categorise cardiac output (low, normal, or high) to understand the underlying pathophysiology and to focus on trends rather than absolute numbers.

Functional Echocardiography: The Physiological Detective

Functional echocardiography at the bedside takes monitoring to another level by answering the “why” questions. fECHO isn’t about diagnosing structural heart disease; it’s about understanding haemodynamic physiology in real time.

A focused scan can quickly assess whether the left ventricle is contracting well. Is there a haemodynamically significant PDA? What does the right ventricle look like? Is it dilated, suggesting pulmonary hypertension? What’s the IVC doing? Is it plump (suggesting volume overload) or collapsing (suggesting hypovolaemia)? How are the systemic and pulmonary flows relating to each other?

These answers directly guide management. Low cardiac output with good contractility but a collapsing IVC? That baby might need volume. Low output with poor contractility? That’s an inotrope scenario. High output with a massive PDA? Time for targeted PDA management.

Pros:

  • Provides direct visualisation of cardiac function and structure
  • Can identify specific causes of haemodynamic compromise
  • Guides precise, targeted interventions
  • Repeatable for monitoring treatment response

Cons:

  • Requires significant training and skill
  • Time-consuming (though focused protocols help)
  • Not continuous, gives snapshots rather than real-time trending
  • Variability between different practitioner capabilities and interpretation

You grab the portable echo machine for Baby J. His left ventricle shows mildly reduced function with a shortening fraction of 22% (normal >28%). His IVC is small and collapsing more than 50% with respiratory variation, suggesting he’s relatively hypovolaemic despite the urine output. There’s no significant PDA, and his right ventricle looks reasonable.

The picture is complete: he’s hypovolaemic with borderline cardiac function, compensating with vasoconstriction to maintain blood pressure at the cost of tissue perfusion.

Pulling It All Together: The Multimodal Monitoring Revolution

Baby J’s story illustrates why multimodal monitoring matters. Blood pressure alone told us he was “fine.” Every other signal told us he wasn’t.

The NIRS showed us his brain was struggling to extract enough oxygen. The electrical cardiometry revealed his cardiac output was inadequate and his systemic vascular resistance was sky-high. The functional echo showed us why: relative hypovolaemia with compromised ventricular function. Each tool added a piece of the puzzle that blood pressure couldn’t provide.

Here’s a practical framework: In a haemodynamically unstable neonate, blood pressure should be just one data point in a constellation of monitoring. If BP is acceptable but NIRS is low, cardiac output is dropping, and echo shows poor filling, you’ve got a problem, regardless of that blood pressure number.

For Baby J, management changed dramatically. Instead of being reassured by his “normal” blood pressure or perhaps blindly starting inotropes, the team gave a careful volume bolus of 10 mL/kg and started low-dose dobutamine to support contractility.

Within an hour, his cerebral NIRS climbed to 62%, cardiac output improved to 200 then 240 mL/kg/min, SVR normalised, and his lactate started trending down. His peripheries warmed up, urine output picked up, and although the blood pressure number barely changed, everything else improved.

This is precision neonatal haemodynamic care. Not treating numbers, but treating babies by understanding their underlying physiology.

Bottom Line

Stop worrying exclusively about blood pressure. It’s one piece of a complex physiological story, and in the NICU, it’s often misleading.

NIRS gives you real-time tissue perfusion data that can detect problems before systemic signs appear. Watch trends, not just numbers.

Electrical cardiometry bridges the gap between pressure and flow, helping you understand whether you’re dealing with a pump problem or a pipes problem.

Functional echocardiography answers the “why,” guiding targeted treatment rather than blind escalation of support.

Multimodal monitoring is the future of NICU haemodynamics. Each tool compensates for the blind spots of the others.

Train your team. These technologies are only as good as the people interpreting them. Invest in education and standardised protocols.

Trust your clinical instinct. When a baby looks poor despite “normal” numbers, you’re probably right. Use these tools to prove it.

Individualise care. The 26-weeker with a MAP of 26 might be beautifully perfused or critically compromised; the number alone can’t tell you which.

KEEP READING

NICU Perfsion HEADER

When the Numbers Lie: Why Your NICU Baby’s Blood Pressure Might Be Lying to You

Copy of Trial (1)

The 100th Bubble Wrap

Disaster HEADER

Open the Front Door to Disaster Medicine

Coeliac disease HEADER

Coeliac disease

Postpartum Depression HEADER (1)

Postpartum depression

Machine Learning in sepsis HEADER

Using machine learning to predict sepsis in kids

DFTB26 is coming to Glasgow

CT Racism HEADER

CT Use in Children with Minor Head or Abdominal Trauma

Methaem HEADER

Congenital Methaemoglobinaemia: How Low Can You Go?

Copy of Trial (1)

Bubble Wrap PLUS – March 2026

CARE study HEADER

Children’s Anti-inflammatory Reliever (CARE) Study: Can children with mild asthma ditch their blue inhaler?

Copy of Trial (1)

The 99th Bubblewrap x Sheffield Children’s ED

Atypical genitalia HEADER

Approach to the neonate with atypical genitalia

Eczema Herpeticum HEADER

Eczema Herpeticum

Copy of Trial (1)

Bubble Wrap PLUS – February 2026

Leave a Reply

Your email address will not be published. Required fields are marked *

DFTB26 is coming to Glasgow!

22-24 June 2026